Extensive research on tea catechins, mainly (-)-epigallocatechin gallate, has shown numerous health promoting effects. However, various clinical studies demonstrated several issues associated with tea catechins which account for their poor systemic bioavailability. In order to improve pharmacological activity and bioavailability of natural tea catechins, two major strategies have been adopted to date which include synthesizing catechin analogs/prodrugs and the development of novel drug delivery systems. In this review, we provide a detailed account of novel synthetic analogs/prodrugs as well as novel drug delivery approaches used for natural tea catechins to make them therapeutically potent drug-like molecules.
The methanolic fraction of the root extract of Mikania cordata was found to possess an inhibitory effect on carrageenin and other mediator-induced oedema; there was a significant inhibition of protein exudation, an increase in peritoneal capillary permeability and leucocyte migration in inflammatory conditions. The extract significantly inhibited both cotton pellet and carrageenin-induced granuloma formation, was effective in experimentally induced arthritic conditions and turpentine-induced joint oedema. The extract also possessed inhibitory effects on sodium urate-induced experimental gout. A significant reduction of pyrexia was also found to occur when rats were treated with the extract. Thus it may be concluded that the methanolic fraction of M. cordata root extract possessed significant antiinflammatory effects in exudative, proliferative and chronic phases of inflammation and demonstrated an antipyretic activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.